Venture
fromsiliconvalleyjournals.com
2 days agoGalvanize raised $100 Million Series C to Advance Non-Pharmacological Therapies
Galvanize Therapeutics raised $100 million in an oversubscribed Series C to expand commercialization and advance Aliya PEF and RheOx therapies.